InvestorsHub Logo
Followers 1
Posts 522
Boards Moderated 0
Alias Born 02/22/2017

Re: None

Friday, 02/26/2021 6:04:32 PM

Friday, February 26, 2021 6:04:32 PM

Post# of 21521
The company stated. “ The availability of increased drug supply will also enable us to look to commence additional informative trials to supplement the data we expect to generate from our NIH supported Phase 2 trial in moderate to severe Alzheimer's Disease."
Does this mean they are planning of holding smaller, shorter trials that will be produced before the end of the current A.D. trial?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News